reference/6151481

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6151481

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review\|Research Support, Non-U.S. Gov't
endingPage	775
issn	0163-3864 1520-6025
issueIdentifier	4
pageRange	765-775
publicationName	Journal of Natural Products
startingPage	765
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dee036e759c010e5dbb2a0639c301310 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c1c4b2239c1fe2047bc2eb3481c88a0a
bibliographicCitation	Shen Y, Cai H, Ma S, Zhu W, Zhao H, Li J, Ye H, Yang L, Zhao C, Huang X, Xiao Z. Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling. J Nat Prod. 2022 Apr 22;85(4):765–75. doi: 10.1021/acs.jnatprod.1c00761. PMID: 35200033.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2733da41763a0620f67ce32369fcb4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5af93dfd43afd6c1e0c1a1706e56dcf3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab336769ac3829a86d128f424a0f5cc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fbdb8c2d473c194837d860abe25b474 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0418-3241 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90b399cd9b5ee117b4c0663e0e9be6b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0779e7c7abbf2fe9d70e1b0936e60c18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_250b38a2e03e0c174bf36cf68505bf08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73822c0a262297e6e803268f0e7c8143 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5710ca9b6792d5fca5b8ce2ad362215c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_071622b3d9f639d86ae61fe63160415d
date	2022-02-24^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/35200033 https://doi.org/10.1021/acs.jnatprod.1c00761
isPartOf	https://portal.issn.org/resource/ISSN/0163-3864 https://portal.issn.org/resource/ISSN/1520-6025 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4987
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling
discusses	http://id.nlm.nih.gov/mesh/M0229085 http://id.nlm.nih.gov/mesh/M0054035 http://id.nlm.nih.gov/mesh/M0003002 http://id.nlm.nih.gov/mesh/M0477916
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D002289Q000378 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002018 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D050796 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002465 http://id.nlm.nih.gov/mesh/D017209 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID472172 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259991 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e75b04b99ad7f9547bbdf30bf933fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77129

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6774

Showing number of triples: 1 to 67 of 67.